is the fda taking tirzepatide off the market says compounding pharmacies can keep making weight-loss med tirzepatide, for now The Impact of New FDA

Mounjaro is administered by weekly subcutaneous injections, and the dose can be adjusted according to tolerability

Compounded GLP-1s are not FDA-approved or evaluated for safety or efficacy, and not available in all states

Minimal downtime

The theory is that the medication-induced slowing of gastric emptying combined with an empty stomach creates a particularly uncomfortable sensation

That is a decision to make with your prescribing provider based on your individual risk tolerance and health status

For brand-name pens, Eli Lilly states that once stored at room temperature, the pen should not be returned to the refrigerator